• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

14/02/2026 17:25

Omkar Pharmachem - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February, 2026

Dear Sir, Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in their meeting held on 14th February, 2026 has considered and approved the following business: 1. The Board approved the Unaudited Financial Results of the Company along with the Limited Review Report for the quarter and Nine Months ended on 31st December, 2025. The Board took note of the completion of the tenure of Mr. Janak Raj Sharma (DIN: 07420418) as an Independent Director of the Company. Mr. Janak Raj Sharma has completed two consecutive terms of five (5) years each and accordingly ceased to be an Independent Director of the Company upon the close of business hours on 12th February, 2026.